Patents
Patents for C07J 3 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by one carbon atom (1,033)
02/2015
02/04/2015CN104327144A 3-羟基-5-雄烯-17β羧酸甲酯的制备方法 Preparation 3- hydroxy-5-carboxylate androstenedione -17β
01/2015
01/15/2015US20150018326 Compositions and methods for inhibiting norovirus infection
01/14/2015CN104277089A 一种雄甾-17β-羧酸的制备方法 One kind androst -17β- acid preparation
12/2014
12/17/2014CN101585862B 甾族化合物 Steroid
09/2014
09/23/2014CA2637548C Novel 11 beta - hydroxyandrosta-4-ene-3-ones
09/04/2014US20140249120 Neuroactive 13, 17-substituted steroids as modulators for gaba type-a receptors
07/2014
07/22/2014US8785425 11β-hydroxyandrosta-4-ene-3-ones
07/01/2014US8765725 Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
06/2014
06/24/2014US8759304 Compositions and methods for increasing telomerase activity
06/19/2014US20140171645 Electrophilic alkylating reagents, their preparation and use
05/2014
05/14/2014CN103797022A 桦木酮酸和Boc-赖氨酸化桦木酮酸的提纯方法,以及利用哌嗪衍生物制备桦木酮酸酰胺的有机合成方法 Birch acid and lysine Boc- of birch acid purification methods, and the use of organic synthetic methods for preparing birch acid amide derivative of piperazine
05/07/2014CN103781794A 用于生产雄甾烷-17-β-羧酸的氟甲基-酯的方法 For the production of androstane -17-β- acid fluoromethyl - method ester
04/2014
04/16/2014CN103732608A A use of a composition comprising of acylated steryl glucoside in the manufacture of a product
04/16/2014CN101974052B Method for synthesizing androstane-3-ketone-4-alkene-17beta carboxylic acid
04/09/2014EP2714711A1 Method for the production of fluoromethyl - esters of androstan- 17 - beta - carboxylic acids
03/2014
03/26/2014EP2710022A2 A use of a composition comprising of acylated steryl glucoside in the manufacture of a product
02/2014
02/13/2014US20140046061 Processes Employing Cyclodextrin Derivative Quaternary Salts
11/2013
11/19/2013US8586770 Unsaturated steroid compounds
11/14/2013US20130303502 Preparations of Hydrophobic Therapeutic Agents, Methods of Manufacture and Use Thereof
10/2013
10/17/2013US20130274460 Electrophilic Reagents for Monohalomethylation, Their Preparation and Their Uses
08/2013
08/14/2013CN101654470B Intermediate used as anti-inflammatory androstane derivative compositions and uses thereof
08/08/2013US20130203718 Progesterone receptor antagonists and uses thereof
07/2013
07/23/2013US8492570 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumor action
07/17/2013CN101384610B Novel 11 beta - hydroxyandrosta-4-ene-3-ones
07/10/2013CN103193844A Method for synthesizing key intermediate of fluticasone propionate
07/04/2013US20130172587 Process for the Preparation of Fluticasone Propionate
07/03/2013CN103183714A Synthetic method for loteprednol
06/2013
06/13/2013WO2013002592A3 Method for purifying high-purity betulonic acid, method for preparing piperazine betulonic acid amide derivative using high-purity betulonic acid and derivative thereof, and method for purifying high-purity boc-lysinated betulonic acid using high-purity betulonic acid
05/2013
05/01/2013CN103073609A Synthesis method of key intermediate 17-beta-carboxylic acid derivative of fluticasone derivative
04/2013
04/25/2013WO2012161559A3 A use of a composition comprising of acylated steryl glucoside in the manufacture of a product
03/2013
03/21/2013US20130072698 Method and Compounds for the Preparation of Monofluoromethylated Biologically Active Organic Compounds
02/2013
02/06/2013CN102911231A Synthetic method of loteprednol immediate
02/06/2013CN101942001B Purification method of loteprednol etabonate
01/2013
01/16/2013CN102180928B 3-beta,5-alpha,6-beta-trihydroxy steroid compounds, and synthesis method and application thereof
01/09/2013CN101759741B Compound and application thereof in preparation of medicine for treating angiogenesis
01/08/2013US8349819 Steroid extraction process from urine sources
01/01/2013US8344168 Process for the preparation of fluticasone propionate
11/2012
11/29/2012WO2012161559A2 A use of a composition comprising of acylated steryl glucoside in the manufacture of a product
11/29/2012WO2012160338A1 Method for the production of fluoromethyl - esters of androstan- 17 - beta - carboxylic acids
11/28/2012CN102802634A 17[beta]-alkyl-17[alpha]-oxy-estratrienes
10/2012
10/24/2012CN101775055B Method for synthesizing 4-trifluoromethyl-4-olefine-3-steroidal ketone compound
09/2012
09/19/2012CN101479291B Amino derivatives of B-homoandrostanes and B-heteroandrostanes
08/2012
08/23/2012US20120214987 Methods and compounds for preparing 3alpha-oxygen substituted steroids
07/2012
07/26/2012WO2012099477A1 Biosurface engineering
07/04/2012CN101659688B Method for recrystallizing and refining fluticasone propionate
06/2012
06/26/2012US8207150 17β-cyano-19-nor-androst-4-ene derivative, its use and medicaments comprising the derivative
06/21/2012US20120157421 17Beta-Alkyl-17Alpha-oxy-estratrienes
06/07/2012US20120142651 Method of treatment of allergic rhinitis
05/2012
05/22/2012US8183402 Industrial method for the synthesis of 17-acetoxy-11β[4-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione and the key intermediates of the process
05/09/2012CN102448978A Novel Glucocorticoid Receptor Agonists
05/08/2012CA2531905C Specific glucocorticosteroid compound having anti-inflammatory activity
04/2012
04/11/2012EP2437746A2 17 beta-alkyl-17 alpha-oxy-estratrienes
04/04/2012EP2435462A1 Novel glucocorticoid receptor agonists
03/2012
03/14/2012CN102372756A Specific glucocorticosteroid compound having anti-inflammatory activity
02/2012
02/16/2012US20120040945 Use of a Glucocorticoid Composition for the Treatment of Severe and Uncontrolled Asthma
01/2012
01/31/2012US8106036 Pharmaceutical compositions-4
01/26/2012WO2012011106A1 Process for the preparation of 17-desoxy-corticosteroids
01/10/2012CA2492079C Microbiological processes for the production of 7 alpha-substituted 11 alpha-hydroxy steroids
12/2011
12/20/2011CA2733294C Pharmaceutical combination of a tiotropium salt and ciclesonide
11/2011
11/01/2011CA2531911C Specific glucocorticosteroid having an anti-inflammatory activity
10/2011
10/26/2011EP2380898A1 Process to make glucocortisoid compounds
10/20/2011US20110257142 Method for preparing 4-[17beta-methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11-beta-yl]benzaldehyde (e)-oxime (asoprisnil)
10/05/2011CN1845933B Specific glucocorticosteriod compound having anti-inflamatory activity
09/2011
09/14/2011CN102180928A 3-beta,5-alpha,6-beta-trihydroxy steroid compounds, and synthesis method and application thereof
09/07/2011EP2363121A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor agonist for the treatment of inflammatory and allergic conditions
09/07/2011CN102175750A Method for analyzing biological samples by using matrix assisted laser desorption ionization-Fourier transform ion cyclotron resonance mass spectra
09/06/2011US8012952 Cationic 17 α-substituted-estradiol derivatives useful as anti-cancer agent
08/2011
08/23/2011CA2478186C Fluorinated 4-azasteroid derivatives as androgen receptor modulators
07/2011
07/27/2011EP2348030A2 17-Alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents
07/27/2011EP1841780B1 Androstane 17-alpha-carbonate derivatives for use in the treatment of allergic and inflammatory conditions
06/2011
06/23/2011US20110146678 Process for improving crystallinity
06/16/2011US20110144071 Crystalline active ingredient microparticles, method for producing the same and use thereof in drugs
05/2011
05/25/2011CN1849330B Specific glucocorticosteroid compound having anti-inflammatory activity
05/18/2011EP2322182A1 Androstenol derivatives as androgen receptor modulator
05/03/2011US7935839 Sepsis treatment methods
05/03/2011US7935837 Process for synthesis of androstane 17-β carbothioic acid and relative compounds thereof
04/2011
04/07/2011US20110081411 Orally Administered Corticosteroid Compositions
03/2011
03/10/2011WO2010139411A3 17β-ALKYL-17α-OXY-ESTRATRIENES
02/2011
02/22/2011US7893284 Oestrogen derivatives as inhibitors of steroid sulphatase
02/16/2011CN101974052A Method for synthesizing androstane-3-ketone-4-alkene-17beta carboxylic acid
02/02/2011EP2032593B1 Amino derivatives of b-homoandrostanes and b-heteroandrostanes
01/2011
01/20/2011US20110014641 Method for measuring aromatase activity
01/12/2011CN101942001A Purification method of loteprednol etabonate
12/2010
12/09/2010US20100311706 Method of treatment of allergic rhinitis
12/09/2010CA2764249A1 17.beta.-alkyl-17.alpha.-oxy-oestratrienes
12/08/2010EP2258375A1 17B-alkyl-17alpha-oxy-estratrienes
12/02/2010WO2010136940A1 Novel glucocorticoid receptor agonists
12/02/2010US20100303758 Novel Glucocorticoid Receptor Agonists
12/02/2010CA2760284A1 Novel glucocorticoid receptor agonists
10/2010
10/14/2010US20100261917 Process for producing vitamin d derivative using photoreaction
10/07/2010US20100255117 Methods and compositions for the treatment of cancer
09/2010
09/02/2010US20100222313 Pharmaceutical compositions-4
08/2010
08/11/2010CN101798331A Process for preparing fluticasone diproprionate superfine particles and product thereof
07/2010
07/27/2010US7763596 Antiinflamamtory agents; immunosuppressants; antiproliferative agents; treating haematology; reduced harmful side-effects
07/27/2010CA2427569C Selective glucocorticoid receptor agonists
07/14/2010CN101775055A Method for synthesizing 4-trifluoromethyl-4-olefine-3-steroidal ketone compound
07/01/2010WO2009108388A8 Enzymatic production or chemical synthesis and uses for 5,7-dienes and uvb conversion products thereof
06/2010
06/30/2010CN101759741A Compound and application thereof in preparation of medicine for treating angiogenesis
06/24/2010WO2010071772A2 Synthesis of 3b-amino-5-cholestene and related 3b-halides involving i-steroid and retro-i-steroid rearrangements
06/24/2010US20100160657 Synthetic mimics of mammalian cell surface receptors: method and compositions
1 2 3 4 5 6 7 8 9 10 11